ITM and CNL Announce the Launch of Actineer, a New Joint Venture in the Global Production of Actinium-225
ITM Isotope Technologies Munich SE
(ITM), a radiopharmaceutical biotech company, and Canadian Nuclear Laboratories
(CNL), which manages and operates the national laboratory at Chalk River,
Ontario on behalf of Atomic Energy of Canada Limited (AECL), announced the
launch of Actineer™ Inc., a new joint venture company between CNL and ITM for
the industrial scale production of Actinium-225 (225Ac).
To read more please visit:
Source: ITM